Aralez Puts Forward Ch. 11 Plan Isolated From Toprol Sale

Aralez Pharmaceuticals Inc. asked a New York bankruptcy court on Tuesday to approve balloting and disclosure materials for a plan to liquidate most of its corporate entities in Chapter 11 while...

Already a subscriber? Click here to view full article